Bone and muscle health in women under 60 after menopause
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study looks at the link between bone density and muscle mass in women under 60 who have gone through menopause. It aims to understand how osteoporosis and muscle loss may be connected, even if you don't have osteoporosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman under 60 years old and have gone through menopause.
- You either have a diagnosis of osteoporosis (based on a DXA scan showing T-score -2.5 or lower) OR you have normal bone density (T-score -1.0 or higher).
- You are willing to sign a consent form to join the study.
- You do not have any disease affecting your nerves or muscles that could cause muscle loss.
- You have not had any recent infections, surgeries, or injuries.
- You do not have a serious mental health condition or memory problems that could affect tests.
- You are not taking medications like corticosteroids, muscle relaxants, or other drugs that change bone or muscle health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a specific exercise program (circuit training) can improve bone density in women after menopause who have low bone mass. It may help strengthen bones and reduce fracture risk.
This study tests whether exercise and nutrition can help prevent bone weakening and muscle loss in middle-aged adults. You'll participate in a prevention program designed to keep your bones and muscles strong as you age.
This study looks at how well your bones and muscles work together. By measuring your bone density and handgrip strength, doctors can better understand your bone health and find ways to keep you strong as you age.
This study uses brain scans (MRI) to look at how the brain might be linked to bone health in women with osteoporosis. It compares women with osteoporosis to healthy women of the same age.
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
This study looks at whether women with osteoporosis after menopause have a higher risk of orthorexia nervosa, an unhealthy obsession with healthy eating. It aims to compare women with and without osteoporosis to understand the connection.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.